1. Mallinckrodt Announces Election of Carlos V. Paya, M.D., Ph.D. to its Board of Directors

    Mallinckrodt Announces Election of Carlos V. Paya, M.D., Ph.D. to its Board of Directors

    May 21, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE:MNK), a leading global specialty pharmaceutical company, announced today the election of Carlos V. Paya, M.D., Ph.D. to the company's Board of Directors. Dr. Paya has 30 years of branded pharmaceutical industry, science and medical practice experience, and joins the Mallinckrodt Board effective tomorrow, May 22, 2019. He will serve as an independent director on the Board's Portfolio Committee...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned